In The News
Test post after maintenance
Construction Test 7
Construction Test 6
Construction Test 5
Construction test article 2
Test – Racing Victoria planned agreement to ‘seriously breach’ competition laws, court hears
Construction test article 1
I’m afraid AI can’t do that: Law firms say smart tech uses limited
Holden dealers reject GM’s bleak alternate reality in class action
Lawyer’s defamation case fails serious harm test, judge finds

Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.

For information on rights and reprints, contact subscriptions@lawyerly.com.au